Jason works with the Hematology sales team at Janssen and looks forward to getting to know the team members on this ride, patients and caregivers, who he works for every day. The father of a close friend lost his father 8 years ago, and he is mindful of how much progress has been made since that time, and knows that today, he would have had a better chance of survival. Being a part of this team helps Jason reflect on the importance of his work. He knows that funds raised by R2V to support the MMRF mission and the work he does at Janssen bring hope and better outcomes to patients.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
